Related Experiment Video
Updated: Mar 2, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer
Lisa M Daum1, Elyse N Reamer1, Julie J Ruterbusch1
1From the Department of Family Medicine and Public Health Sciences (ENR, JX), Department of Oncology (JJR), and Department of Anesthesiology (JL), Wayne State University School of Medicine (LMD), Detroit, MI; and the Department of Medicine, Michigan State University, East Lansing (MH-R).
Background:
Controversy surrounds treatment for localized prostate cancer (LPC).
Objectives:
To assess men's localized prostate cancer (LPC) knowledge and its association with decision-making difficulty, satisfaction and regret.
Methods:
Population-based sample of 201 men (104 white, 97 black), ≤ 75 years with newly diagnosed LPC completed a self-administered survey.
Results:
Mean age was 61(±7.6) years; two-thirds had less than a Bachelor's degree. Mean LPC knowledge was low, 5.87 (±2.53, maximum score 11). More than a third of men who received surgery or radiation did not know about serious long-term treatment side effects. Fewer than half of the men correctly answered comparative side effect and survival benefit questions between surgery and radiation. Knowledge gaps were greatest among black men, men with lower education, single men. Tumor aggressiveness (i.e. PSA level, Gleason score) and treatment choice were not associated with knowledge. Knowledge was not associated with decisional satisfaction or regret. However, greater knowledge was associated with greater decision-making difficulty (P = .018).
Conclusions:
Significant LPC knowledge gaps existed across groups, with greater knowledge gaps among black men. The association of decision-making difficulty with knowledge was independent of race. Better patient education is needed, but may not alleviate men's decision-making difficulty due to inherent scientific uncertainty.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Nurses' Legal Responsibilities I
The legal responsibilities of a nurse regarding informed consent include the following:
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...